Vezf1 regulates cardiac structure and contractile function
Jere Paavola,
Tarja Alakoski,
Johanna Ulvila,
Teemu Kilpiö,
Juuso Sirén,
Sanni Perttunen,
Suneeta Narumanchi,
Hong Wang,
Ruizhu Lin,
Katja Porvari,
Juhani Junttila,
Heikki Huikuri,
Katariina Immonen,
Päivi Lakkisto,
Johanna Magga,
Ilkka Tikkanen,
Risto Kerkelä
Affiliations
Jere Paavola
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland
Tarja Alakoski
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Finland
Johanna Ulvila
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Finland
Teemu Kilpiö
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
Juuso Sirén
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland
Sanni Perttunen
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland
Suneeta Narumanchi
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland
Hong Wang
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland
Ruizhu Lin
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland
Katja Porvari
Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Department of Forensic Medicine, Research Unit of Internal Medicine, University of Oulu, Oulu, Finland
Juhani Junttila
Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Division of Cardiology, Research Unit of Internal Medicine, University of Oulu and Oulu University Hospital, Oulu, Finland
Heikki Huikuri
Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Division of Cardiology, Research Unit of Internal Medicine, University of Oulu and Oulu University Hospital, Oulu, Finland
Katariina Immonen
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland
Päivi Lakkisto
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland; Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Johanna Magga
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Finland
Ilkka Tikkanen
Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, Helsinki, Finland; Abdominal Center, Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Risto Kerkelä
Research Unit of Biomedicine, Department of Pharmacology and Toxicology, University of Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; Corresponding author: Prof. Risto Kerkelä, MD, PhD, Research Unit of Biomedicine, University of Oulu, P.O. BOX 5000, FI-90014, Oulu, Finland.
Background: Vascular endothelial zinc finger 1 (Vezf1) is a transcription factor previously shown to regulate vasculogenesis and angiogenesis. We aimed to investigate the role of Vezf1 in the postnatal heart. Methods: The role of Vezf1 in regulating cardiac growth and contractile function was studied in zebrafish and in primary cardiomyocytes. Findings: We find that expression of Vezf1 is decreased in diseased human myocardium and mouse hearts. Our experimental data shows that knockdown of zebrafish Vezf1 reduces cardiac growth and results in impaired ventricular contractile response to β-adrenergic stimuli. However, Vezf1 knockdown is not associated with dysregulation of cardiomyocyte Ca2+ transient kinetics. Gene ontology enrichment analysis indicates that Vezf1 regulates cardiac muscle contraction and dilated cardiomyopathy related genes and we identify cardiomyocyte Myh7/β-MHC as key target for Vezf1. We further identify a key role for an MCAT binding site in the Myh7 promoter regulating the response to Vezf1 knockdown and show that TEAD-1 is a binding partner of Vezf1. Interpretation: We demonstrate a role for Vezf1 in regulation of compensatory cardiac growth and cardiomyocyte contractile function, which may be relevant in human cardiac disease. Keywords: Vezf1, Cardiac hypertrophy, Cardiac contractile function, TEAD-1